The WACC of Atara Biotherapeutics Inc (ATRA) is 17.7%.
Range | Selected | |
Cost of equity | 6.60% - 8.50% | 7.55% |
Tax rate | -% - -% | -% |
Cost of debt | 7.00% - 49.90% | 28.45% |
WACC | 6.8% - 28.7% | 17.7% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.59 | 0.64 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 6.60% | 8.50% |
Tax rate | -% | -% |
Debt/Equity ratio | 0.96 | 0.96 |
Cost of debt | 7.00% | 49.90% |
After-tax WACC | 6.8% | 28.7% |
Selected WACC | 17.7% | |